These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 11564593)

  • 1. Immune dysfunction and immune restoration disease in HIV patients given highly active antiretroviral therapy.
    Price P; Mathiot N; Krueger R; Stone S; Keane NM; French MA
    J Clin Virol; 2001 Oct; 22(3):279-87. PubMed ID: 11564593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MHC haplotypes affect the expression of opportunistic infections in HIV patients.
    Price P; Keane NM; Stone SF; Cheong KY; French MA
    Hum Immunol; 2001 Feb; 62(2):157-64. PubMed ID: 11182226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence and risk of immune restoration disease in HIV-infected patients treated with highly active antiretroviral therapy.
    Jevtović DJ; Salemović D; Ranin J; Pesić I; Zerjav S; Djurković-Djaković O
    HIV Med; 2005 Mar; 6(2):140-3. PubMed ID: 15807721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune restoration disease: a consequence of dysregulated immune responses after HAART.
    Stone SF; Price P; French MA
    Curr HIV Res; 2004 Jul; 2(3):235-42. PubMed ID: 15279587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases.
    Price P; Morahan G; Huang D; Stone E; Cheong KY; Castley A; Rodgers M; McIntyre MQ; Abraham LJ; French MA
    AIDS; 2002 Oct; 16(15):2043-7. PubMed ID: 12370503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of serum soluble CD30 levels and serum CD26 (DPPIV) enzyme activity as markers of type 2 and type 1 cytokines in HIV patients receiving highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Stone SF; French MA
    Clin Exp Immunol; 2001 Oct; 126(1):111-6. PubMed ID: 11678906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus (CMV) retinitis immune restoration disease occurs during highly active antiretroviral therapy-induced restoration of CMV-specific immune responses within a predominant Th2 cytokine environment.
    Stone SF; Price P; Tay-Kearney ML; French MA
    J Infect Dis; 2002 Jun; 185(12):1813-7. PubMed ID: 12085331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART.
    Stone SF; Price P; Keane NM; Murray RJ; French MA
    HIV Med; 2002 Jan; 3(1):21-7. PubMed ID: 12059947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB; Briggs JW; McDonald JC; Freeman WR; Morse LS
    Retina; 2001; 21(4):339-43. PubMed ID: 11508879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV; Feinberg J; Hutchins RK; Frame RD; Schmidt DK; Viswanathan MN; Lalezari JP; McCune JM
    J Infect Dis; 2001 Apr; 183(8):1285-9. PubMed ID: 11262214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological profiles of immune restoration disease presenting as mycobacterial lymphadenitis and cryptococcal meningitis.
    Tan DB; Yong YK; Tan HY; Kamarulzaman A; Tan LH; Lim A; James I; French M; Price P
    HIV Med; 2008 May; 9(5):307-16. PubMed ID: 18400078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART.
    Gerna G; Piccinini G; Genini E; Percivalle E; Zavattoni M; Lilleri D; Testa L; Comolli G; Maserati R; Baldanti F; Maccario R; Monforte AD; Revello MG
    J Acquir Immune Defic Syndr; 2001 Dec; 28(4):320-31. PubMed ID: 11707667
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
    Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
    Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM; Fortin E; Lindblad AS; Griffiths P; Metcalf JA; Robinson MR; Manischewitz J; Baird B; Perry C; Kidd IM; Vrabec T; Davey RT; Falloon J; Walker RE; Kovacs JA; Lane HC; Nussenblatt RB; Smith J; Masur H; Polis MA
    JAMA; 1999 Nov; 282(17):1633-7. PubMed ID: 10553789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK; Karavellas MP; MacDonald JC; Plummer DJ; Freeman WR
    Retina; 2000; 20(2):151-5. PubMed ID: 10783947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.
    Komanduri KV; Viswanathan MN; Wieder ED; Schmidt DK; Bredt BM; Jacobson MA; McCune JM
    Nat Med; 1998 Aug; 4(8):953-6. PubMed ID: 9701250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune restoration disease in HIV-infected individuals receiving highly active antiretroviral therapy: clinical and immunological characteristics.
    de Boer MG; Kroon FP; Kauffmann RH; Vriesendorp R; Zwinderman K; van Dissel JT
    Neth J Med; 2003 Dec; 61(12):408-12. PubMed ID: 15025416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM; Price P; Lee S; Almeida CA; Stone SF; James I; French MA
    HIV Med; 2004 Nov; 5(6):407-14. PubMed ID: 15544692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy.
    Almeida CA; Price P; French MA
    AIDS Res Hum Retroviruses; 2002 Dec; 18(18):1351-5. PubMed ID: 12487806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC; Karavellas MP; Torriani FJ; Morse LS; Smith IL; Reed JB; Freeman WR
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.